Garner Thomas

Insider CIK 1996325 · LXRX SVP, Chief Commercial Officer · ACAD EVP, Chief Commercial Officer

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
ACAD ACADIA PHARMACEUTICALS INC	A Award deriv	2026-03-06	2026-03-10	28,493	—	$0	28,493	SEC↗
ACAD ACADIA PHARMACEUTICALS INC	A Award deriv	2026-03-06	2026-03-10	97,947	—	$0	97,947	SEC↗
ACAD ACADIA PHARMACEUTICALS INC	A Award deriv	2024-12-09	2024-12-10	235,849	—	$0	235,849	SEC↗
ACAD ACADIA PHARMACEUTICALS INC	A Award deriv	2024-12-09	2024-12-10	45,372	—	$0	45,372	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	A Award deriv	2024-02-08	2024-02-12	227,130	—	$0	227,130	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	A Award deriv	2024-02-08	2024-02-12	227,130	—	$0	227,130	SEC↗
LXRX LEXICON PHARMACEUTICALS, I	A Award deriv	2023-10-09	2023-10-11	248,923	—	$0	248,923	SEC↗